Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Juan J Gomez-Reino*, Loreto Carmona and the BIOBADASER Group

Arthritis Research & Therapy 2006, 8:R29 doi:10.1186/ar1881

Accesses  

  • Last 30 days: 96 accesses
  • Last year: 1242 accesses
  • All time: 10424 accesses

Cited by

BioMed Central: 6 citations

Research article   Open Access

Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study

Sarika Ogale, Elena Hitraya, Henry J Henk BMC Musculoskeletal Disorders 2011, 12:204 (19 September 2011)

Research article   Open Access Highly Accessed

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

Martin Rudwaleit, Filip Van den Bosch, Martina Kron, Sonja Kary, Hartmut Kupper Arthritis Research & Therapy 2010, 12:R117 (16 June 2010)

Research article   Open Access

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists

Federico Navarro-Sarabia, Dolores Ruiz-Montesinos, Blanca Hernandez, Victoria Navarro-Compán, Sara Marsal, Mireia Barcelo, Eva Perez-Pampín, Juan J Gómez-Reino BMC Musculoskeletal Disorders 2009, 10:91 (23 July 2009)

Research article   Open Access Highly Accessed

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

Amr A Saad, Darren M Ashcroft, Kath D Watson, Kimme L Hyrich, Peter R Noyce, Deborah PM Symmons, Arthritis Research & Therapy 2009, 11:R52 (8 April 2009)

Review   Free Highly Accessed

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

Andrea Rubbert-Roth, Axel Finckh Arthritis Research & Therapy 2009, 11(Suppl 1):S1 (6 April 2009)

Research article   Open Access

Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden

Lars Kristensen, Tore Saxne, Jan-Åke Nilsson, Pierre Geborek Arthritis Research & Therapy 2006, 8:R174 (22 November 2006)